This post was originally published on this site
Earnings before interest, taxes, depreciation and amortisation (EBITDA), adjusted for one-off items, for the division reached 824 million euros, the diversified group reported on Thursday.
In an unscheduled release last week, Merck raised its full-year profit forecast, citing very strong performance at its Life Science unit, and published forecast-beating group earnings for the quarter.
